Business

Can Fiji Prioritize Quality Over Quantity in Medical Training?
Business Can Fiji Prioritize Quality Over Quantity in Medical Training?

The rapid expansion of Fiji’s healthcare workforce has reached a critical juncture where the sheer number of graduates may soon outpace the system’s ability to provide meaningful clinical mentorship. As the Fiji Medical Association (FMA) charts a new course under the leadership of Dr. Ronald Kumar,

Why Is Arada Investing $544 Million in UAE Healthcare?
Business Why Is Arada Investing $544 Million in UAE Healthcare?

With a portfolio valued at approximately AED 130 billion and a delivery track record of over 10,000 homes, Ahmed Alkhoshaibi has steered Arada to become a formidable force in the Middle Eastern real estate market. His strategy transcends traditional property development, focusing instead on

What Is the New Medicare GLP-1 Bridge Program?
Business What Is the New Medicare GLP-1 Bridge Program?

Faisal Zain brings a unique perspective to the evolving landscape of federal healthcare policy, combining his deep technical knowledge of medical device manufacturing with a keen understanding of diagnostic and treatment integration. As Medicare breaks a long-standing tradition by introducing

Modernizing Healthcare Payments for a Better Patient Experience
Business Modernizing Healthcare Payments for a Better Patient Experience

As a seasoned leader in financial operations with over a decade of experience, Stephanie O’Connor has seen firsthand how the intersection of technology and empathy defines the modern patient journey. Currently serving as the Director of Operations and Merchant Experience at Wind River Payments, she

Angelini Pharma Expands in US With $4.1 Billion Catalyst Deal
Business Angelini Pharma Expands in US With $4.1 Billion Catalyst Deal

The landscape of global healthcare witnessed a seismic shift recently as Angelini Pharma, a venerable Italian powerhouse with deep European roots, officially announced its strategic acquisition of Florida-based Catalyst Pharmaceuticals for approximately 4.1 billion dollars. This transaction

Can Private Equity Pivot to Focus on Patient Outcomes?
Business Can Private Equity Pivot to Focus on Patient Outcomes?

The convergence of private capital and medical services has reached a critical tipping point where traditional aggressive consolidation strategies no longer satisfy the demands of modern regulatory bodies or consumer expectations. This fundamental shift marks the end of an era defined by rapid-fire

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later